Rating Agencies

Share recommendations

Made with ❤ von BGFL
#BGFLapp * beta

Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.

20.12.2023 12:07PM

M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG (ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 11,90 auf EUR 13,20. Zusammenfassung: Im November stärkte M1 seine Botox-Lieferkette durch den Erwerb der Nutri Care GmbH und ihrer hu [ … ]
15.12.2023 09:31AM
Study issued by GBC AG

HAEMATO AG (von GBC AG): suspended

suspended
Delisting of the HAEMATO share to take place from February 2023; price potential not yet exhausted; GBC-rating and GBC-price target suspended   HAEMATO has announced the termination of the inclusion of the shares in the open market of 30 November 2023. The shares are to be delisted after expiry of the notice period, at the latest by the end  [ … ]
13.12.2023 10:01AM

Haemato AG (von First Berlin Equity Research GmbH): Not Rated

Not Rated
First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin hat seine bisherige Buy-Empfehlung und sein bisheriges Kursziel von EUR 34,00 wegen des bevorstehenden Delistings zurückgenommen. Zusammenfassung: Haemato wird die Notierung ihrer Aktien im Open Market der Frank [ … ]
13.12.2023 09:41AM

MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 62,00. Zusammenfassung: Der NAVPS lag zum Neunmonatszeitpunkt bei €50,40 gegenüber €31,90 in 9M/22 (+58%) Die schlep [ … ]
20.11.2023 10:01AM
Study issued by GBC AG

Coreo AG (von GBC AG): BUY

BUY
H1 2023: Large portfolio acquisitions to come in 2024; EBIT break-even expected in 2024; price target: € 1.00; rating: BUY   In the first six months of 2023, Coreo AG was able to increase rental income to € 3.17 million (previous year: € 2.82 million). As there were no property additions in both the 2022 financial year and the [ … ]
20.11.2023 09:02AM
Study issued by NuWays AG

SMARTBROKER Holding AG (von NuWays AG): BUY

BUY
Migration well progressed // New arrangement with DAB Smartbroker announced to have made significant progress regarding the migration of customers, transactions and AuC´s from SB1 (old Smartbroker) to Smartbroker+: 65% of active SB1 customers successfully migrated. This translates into 90k of the former 228k customers (excl. 44k FondDis [ … ]
07.11.2023 11:51AM

Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG (von First Berlin Equity Research GmbH): BUY

BUY
First Berlin Equity Research has published a research update on Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG (ISIN: DE0008041005). Analyst Christian Orquera reiterated his BUY rating and maintained his EUR 1.80 price target. Abstract: DEWB has published its financial statement for H1/23. Overall results were roughly as expected.  [ … ]
18.10.2023 02:51PM

MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 59,00 auf EUR 62,00. Zusammenfassung: Der Sechsmonatsbericht spiegelt die Kursentwicklung der beiden wichtigsten börsennotierten B [ … ]
16.10.2023 09:16AM

CR Energy AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu CR Energy AG (ISIN: DE000A2GS625) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 50,00 auf EUR 48,00. Zusammenfassung: Der Sechsmonatsbericht zeigt eine weitere gute Portfolioperformance, die den Ruf der kürzlich umbenannte [ … ]
31.03.2022 11:02AM
Study issued by GBC AG

Bitcoin Group SE (von GBC AG): BUY

BUY
Preliminary business figures 2021 - Very good development with results above our forecasts On March 29, 2022, Bitcoin Group SE published the preliminary business figures for the year 2021. Accordingly, sales increased by 56.6% to EUR23.5 million (previous year: EUR15.0 million). EBITDA increased by 85.7% to EUR19.5 million (previous year: EUR10. [ … ]

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
          Rating Agencies          
          Qualitätsjournalismus · Made in Germany © 2024          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL